http://www.inveslogic.com/tags/mr Blog Articles Tagged with 'mr' at http://www.inveslogic.com en http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149846?rsstype=tag&tag=mr As Greg Scott, our Executive Editor, wrote last week, the 4th ChinaBio Investor Forum showed activity in China biopharma remains high (see story). At the forum, young biopharmas showed off their innovation and VCs were interested. Still, it is true t... Sun, 21 Dec 2008 15:27:34 -0500 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149846?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1148054?rsstype=tag&tag=mr Last week was the quarterly high watermark for earnings announcements in China Biotech. As a basic theme, the reports seemed each in their own way to reiterate the same message: the majority of China biopharmas reported higher revenues, though the go... Mon, 17 Nov 2008 04:40:30 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1148054?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1148069?rsstype=tag&tag=mr Last week was the quarterly high watermark for earnings announcements in China Biotech. As a basic theme, the reports seemed each in their own way to reiterate the same message: the majority of China biopharmas reported higher revenues, though the go... Mon, 17 Nov 2008 04:40:30 -0500 http://www.inveslogic.com/sectors/directory/china-stock-blog/1148069?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1119801?rsstype=tag&tag=mr The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratories made a long-awaited announcement: the FDA accepted its China-developed data for review (see story)... Sun, 07 Sep 2008 08:59:55 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1119801?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1119824?rsstype=tag&tag=mr The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratories made a long-awaited announcement: the FDA accepted its China-developed data for review (see story)... Sun, 07 Sep 2008 08:59:55 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119824?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1118934?rsstype=tag&tag=mr Mindray Medical International Ltd. (MR)Q2 2008 Earnings Call... Thu, 04 Sep 2008 15:46:13 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118934?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1112338?rsstype=tag&tag=mr As an additional follow-up to my ADR series (see previous articles on energy sector ADRs and financial sector ADRS), I am going to take a look at the Chinese and Hong Kong healthcare sector. There are 6 key Chinese and Hong Kong ADRs within the GICS ... Fri, 08 Aug 2008 05:22:56 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1112338?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1112346?rsstype=tag&tag=mr July was a volatile month for the U.S. markets. The Dow Jones Industrial Average started the month with some big losses, even closing below 11,000 for the first time in two years on July 15th. But since then, the index has reclaimed some of the losse... Wed, 06 Aug 2008 15:51:50 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1112346?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1105486?rsstype=tag&tag=mr Comparing to what happened to Chinese stocks listed on U. S. stock exchanges, the drop in major U. S. equity indexes is minor, though the Dow Jones Industrial Average did lose more than 10% in just one month (10.19%). During the same time period, the... Thu, 03 Jul 2008 07:41:56 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1105486?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1094197?rsstype=tag&tag=mr Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedical company. The third largest pharmaceutical company in Japan, Daiichi Sankyo [TSE: 4568.JP], annou... Sun, 15 Jun 2008 04:47:25 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1094197?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1094223?rsstype=tag&tag=mr Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedical company. The third largest pharmaceutical company in Japan, Daiichi Sankyo [TSE: 4568.JP], annou... Sun, 15 Jun 2008 04:47:25 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1094223?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/internet-stock-blog/1094255?rsstype=tag&tag=mr Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedical company. The third largest pharmaceutical company in Japan, Daiichi Sankyo [TSE: 4568.JP], annou... Sun, 15 Jun 2008 04:47:25 -0400 http://www.inveslogic.com/sectors/directory/internet-stock-blog/1094255?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/us-market-blog/1094287?rsstype=tag&tag=mr Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedical company. The third largest pharmaceutical company in Japan, Daiichi Sankyo [TSE: 4568.JP], annou... Sun, 15 Jun 2008 04:47:25 -0400 http://www.inveslogic.com/sectors/directory/us-market-blog/1094287?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1094226?rsstype=tag&tag=mr Mindray Medical International Limited (NYSE: MR) announced during the past week that two medical products have received 510(k) clearance for US use from the FDA. One product, the AS3000 next generation anesthesia delivery system, was developed by M... Sun, 15 Jun 2008 04:40:28 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1094226?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/internet-stock-blog/1094258?rsstype=tag&tag=mr Mindray Medical International Limited (NYSE: MR) announced during the past week that two medical products have received 510(k) clearance for US use from the FDA. One product, the AS3000 next generation anesthesia delivery system, was developed by M... Sun, 15 Jun 2008 04:40:28 -0400 http://www.inveslogic.com/sectors/directory/internet-stock-blog/1094258?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/us-market-blog/1094290?rsstype=tag&tag=mr Mindray Medical International Limited (NYSE: MR) announced during the past week that two medical products have received 510(k) clearance for US use from the FDA. One product, the AS3000 next generation anesthesia delivery system, was developed by M... Sun, 15 Jun 2008 04:40:28 -0400 http://www.inveslogic.com/sectors/directory/us-market-blog/1094290?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/energy-stock-blog/1091791?rsstype=tag&tag=mr CreditSights has raised its earnings estimates for oil and gas companies, based on a revised assumption of $106-a-barrel oil and other recent developments. Among integrated companies, Hess (NYSE: HES) and Murphy Oil (NYSE: MUR) post the biggest incre... Thu, 12 Jun 2008 03:06:10 -0400 http://www.inveslogic.com/sectors/directory/energy-stock-blog/1091791?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/etf-investor/1091809?rsstype=tag&tag=mr CreditSights has raised its earnings estimates for oil and gas companies, based on a revised assumption of $106-a-barrel oil and other recent developments. Among integrated companies, Hess (NYSE: HES) and Murphy Oil (NYSE: MUR) post the biggest incre... Thu, 12 Jun 2008 03:06:10 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1091809?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/us-market-blog/1091898?rsstype=tag&tag=mr CreditSights has raised its earnings estimates for oil and gas companies, based on a revised assumption of $106-a-barrel oil and other recent developments. Among integrated companies, Hess (NYSE: HES) and Murphy Oil (NYSE: MUR) post the biggest incre... Thu, 12 Jun 2008 03:06:10 -0400 http://www.inveslogic.com/sectors/directory/us-market-blog/1091898?rsstype=tag&tag=mr http://www.inveslogic.com/sectors/directory/china-stock-blog/1073563?rsstype=tag&tag=mr Mindray Medical International Limited (MR) reported earnings earlierthis month and the news was encouraging. After a tumultuous declinelate in the first quarter, the stock had begun to rebound, and thenmoved decidedly higher on the announcement. Re... Thu, 22 May 2008 03:06:47 -0400 http://www.inveslogic.com/sectors/directory/china-stock-blog/1073563?rsstype=tag&tag=mr